Počet záznamů: 1  

Bone marrow dendritic cell-based anticancer vaccines

  1. 1.
    0191425 - UMG-J 20010497 RIV US eng J - Článek v odborném periodiku
    Indrová, Marie - Mendoza, Luis - Reiniš, Milan - Vonka, V. - Šmahel, M. - Němečková, Š. - Jandlová, Táňa - Bubeník, Jan
    Bone marrow dendritic cell-based anticancer vaccines.
    Advances in Experimental Medicine and Biology. Roč. 495, - (2001), s. 355-358. ISSN 0065-2598
    Grant CEP: GA MZd NC5526; GA ČR GA312/98/0826; GA ČR GA312/99/0542; GA ČR GA301/00/0114; GA ČR GA301/01/0985; GA AV ČR IAA7052002
    Výzkumný záměr: CEZ:AV0Z5052915
    Klíčová slova: HPV16 * dendritic cells * tumour vaccines
    Kód oboru RIV: EB - Genetika a molekulární biologie
    Impakt faktor: 0.513, rok: 2000

    Murine carcinoma MK16 was utilized to compare the efficacz of loading dendritic cells with tumour lysates and a synthetic HPV16 E7-derived peptide. It has been found that loading the DC with tumour lysate is more efficient for .I.in vitro priming of syngeneic spleen cells than loading with the immunodominant peptide and that two established DC lines are also able to prime the mitogenic activity of syngeneic spleen cells after loading with antigen.
    Trvalý link: http://hdl.handle.net/11104/0087178